A splice-junction mutation responsible for familial apolipoprotein A-II deficiency
- PMID: 2107739
- PMCID: PMC1683675
A splice-junction mutation responsible for familial apolipoprotein A-II deficiency
Abstract
The first case of familial apolipoprotein A-II (apo A-II) deficiency was recently reported from Hiroshima, Japan, and designated apo A-IIHiroshima. The proband had no immunologically detectable apo A-II in her plasma. DNA sequence analysis showed that the proband was homozygous for a G----A transition at position 1 of intron 3 of the apo A-II gene. A sister of the proband, who had an intermediate level of plasma apo AII, was shown to be heterozygous for this base substitution. This splice-junction alteration is most likely responsible for apo A-II deficiency, since it would be expected to completely block splicing of intron 3 from the primary transcript and therefore prevent formation of functional mRNA. This deficiency seems to have little influence either on lipid and lipoprotein profiles or on the occurrence of coronary artery disease.
Similar articles
-
Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene.Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2793-7. doi: 10.1073/pnas.88.7.2793. Proc Natl Acad Sci U S A. 1991. PMID: 1901417 Free PMC article.
-
Expression of the human serum apolipoprotein AI and AII genes in Xenopus laevis oocytes. Lipid-associated secretion of gene products.Biol Chem Hoppe Seyler. 1988 Jul;369(7):585-93. doi: 10.1515/bchm3.1988.369.2.585. Biol Chem Hoppe Seyler. 1988. PMID: 2852015
-
[Apolipoprotein A I-C III-A IV deficiency].Nihon Rinsho. 1994 Dec;52(12):3253-6. Nihon Rinsho. 1994. PMID: 7853719 Review. Japanese.
-
Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.Metabolism. 1985 Aug;34(8):754-64. doi: 10.1016/0026-0495(85)90027-7. Metabolism. 1985. PMID: 3927110
-
Familial hypoalphalipoproteinemias.Clin Invest Med. 1990 Aug;13(4):202-10. Clin Invest Med. 1990. PMID: 2119926 Review.
Cited by
-
Apolipoprotein A-II, a Player in Multiple Processes and Diseases.Biomedicines. 2022 Jul 2;10(7):1578. doi: 10.3390/biomedicines10071578. Biomedicines. 2022. PMID: 35884883 Free PMC article. Review.
-
ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.J Lipid Res. 2011 Aug;52(8):1461-70. doi: 10.1194/jlr.M013235. Epub 2011 May 26. J Lipid Res. 2011. PMID: 21622630 Free PMC article.
-
High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli.J Lipid Res. 2012 Aug;53(8):1708-15. doi: 10.1194/jlr.D028043. Epub 2012 May 25. J Lipid Res. 2012. PMID: 22636422 Free PMC article.
-
Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits.Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):224-31. doi: 10.1161/ATVBAHA.112.300445. Epub 2012 Dec 13. Arterioscler Thromb Vasc Biol. 2013. PMID: 23241412 Free PMC article.
-
Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility.Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14788-94. doi: 10.1073/pnas.93.25.14788. Proc Natl Acad Sci U S A. 1996. PMID: 8962133 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases